Dendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14586)A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14579)Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-20Viro-immune therapy: A new strategy for treatment of pancreatic cancer
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2016-01-14 / World J. Gastroenterol. 2016 Jan;22(2):748-63Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-12-16 / Mol. Cancer 2015 Dec;14:210Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-29 / Oncotarget 2015 Sep;6(29):27751-62A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2015-09-15 / Oncotarget 2015 Sep;6(27):23462-79Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-08-24 / Technol. Cancer Res. Treat. 2016 10;15(5):NP83-94Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-06-11 / Viruses 2015 Jun;7(6):2980-98IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de